FDA Grand Rounds – NCTR Presentations
FDA Grand Rounds by NCTR scientists. Each 45-minute session presents a key public health challenge and how FDA is applying science to its regulatory activities.
NCTR Grand Rounds Presentations
2021
Studies of SARS-CoV-2 NSP1 and Envelope Protein
Presented by Marli Azevedo, Ph.D., Research Biologist, Division of Microbiology
2020
Nanotechnology: Over a Decade of Progress and Innovation at FDA
Presented by Anil Patri, Ph.D., Chair, Nanotechnology Task Force, Director, Nanocore
Artificial Intelligence for Regulatory Science Research
Presented by Weida Tong, Ph.D., Director of Division of Bioinformatics and Biostatistics
2019
Overview of FDA’s Perinatal Health Center of Excellence: Development and Validation of Predictive Systems
Presented by Amy Inselman, Ph.D., Division of Systems Biology, Biomarkers and Alternative Models Branch
2018
Bisphenol A: Toxicology and Pharmacokenetic Data to Inform Ongoing Safety Assessments
Presented by Barry Delclos, Ph.D., Research Pharmacologist, Division of Biochemical Toxicology
Ethnicity- and Gender-Related Differences in Alzheimer’s Disease
Presented by Sherry Ferguson, Ph.D., Research Psychologist, Division of Neurotoxicology, and Vijayalakshmi Varma, Ph.D., Research Biologist